Calton & Associates’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,500
| Closed | -$51K | – | 368 |
|
|
2022
Q1 | $51K | Buy |
12,500
+1,000
| +9% | +$4.08K | 0.02% | 346 |
|
|
2021
Q4 | $41K | Sell |
11,500
-10,000
| -47% | -$35.7K | 0.01% | 362 |
|
|
2021
Q3 | $78K | Hold |
21,500
| – | – | 0.02% | 390 |
|
|
2021
Q2 | $94K | Hold |
21,500
| – | – | 0.02% | 400 |
|
|
2021
Q1 | $88K | Hold |
21,500
| – | – | 0.02% | 390 |
|
|
2020
Q4 | $86K | Buy |
21,500
+1,000
| +5% | +$4K | 0.02% | 372 |
|
|
2020
Q3 | $55K | Hold |
20,500
| – | – | 0.01% | 340 |
|
|
2020
Q2 | $56K | Hold |
20,500
| – | – | 0.01% | 324 |
|
|
2020
Q1 | $48K | Buy |
20,500
+3,000
| +17% | +$7.02K | 0.01% | 294 |
|
|
2019
Q4 | $82K | Buy |
+17,500
| New | +$82K | 0.02% | 353 |
|
|
2018
Q1 | – | Sell |
-3,500
| Closed | -$7K | – | 1378 |
|
|
2017
Q4 | $7K | Buy |
+3,500
| New | +$7K | ﹤0.01% | 1179 |
|